Patton Fund Management, Inc. Eli Lilly & CO Transaction History

Patton Fund Management, Inc.

$471 Million
Q2 2024

A detailed history of Patton Fund Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Patton Fund Management, Inc. holds 7,589 shares of LLY stock, worth $6.72 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares

7,589

Previous 8,979 15.48%

Holding current value

$6.72 Million

Previous $6.99 Million 1.65%

% of portfolio

1.46%

Previous 1.28%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$724.87 - $909.04 $1.01 Million - $1.26 Million	-1,390 Reduced 15.48%	7,589 $6.87 Million
Q1 2024 May 08, 2024	BUY	$592.2 - $792.28 $2.25 Million - $3.01 Million	3,794 Added 73.17%	8,979 $6.99 Million
Q4 2023 Jan 12, 2024	SELL	$525.19 - $619.13 $14,180 - $16,716	-27 Reduced 0.52%	5,185 $3.02 Million
Q3 2023 Oct 31, 2023	SELL	$434.7 - $599.3 $1.57 Million - $2.16 Million	-3,605 Reduced 40.89%	5,212 $2.8 Million
Q2 2023 Jul 12, 2023	BUY	$350.74 - $468.98 $1.56 Million - $2.08 Million	4,435 Added 101.21%	8,817 $4.13 Million
Q1 2023 Apr 06, 2023	SELL	$310.63 - $364.82 $882,189 - $1.04 Million	-2,840 Reduced 39.32%	4,382 $1.5 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $67,847 - $79,055	-211 Reduced 2.84%	7,222 $2.64 Million
Q3 2022 Oct 21, 2022	SELL	$296.48 - $337.87 $162,471 - $185,152	-548 Reduced 6.87%	7,433 $2.4 Million
Q2 2022 Jul 22, 2022	SELL	$278.73 - $327.27 $1.62 Million - $1.9 Million	-5,804 Reduced 42.1%	7,981 $2.59 Million
Q1 2022 Apr 20, 2022	SELL	$234.69 - $291.66 $132,834 - $165,079	-566 Reduced 3.94%	13,785 $3.95 Million
Q4 2021 Jan 21, 2022	BUY	$224.85 - $279.04 $3.23 Million - $4 Million	14,351 New	14,351 $3.96 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $842B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patton Fund Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patton Fund Management, Inc. with notifications on news.

Account

Patton Fund Management, Inc. Eli Lilly & CO Transaction History